Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07720674

SEE FAR CBT Intervention for Adults With PTSD

This single-arm clinical intervention study evaluates a 12-session SEE FAR CBT intervention for adults aged 18 years and older with posttraumatic stress disorder (PTSD). SEE FAR CBT is a trauma-focused cognitive-behavioral treatment approach. Participants will complete self-report psychological questionnaires at three time points: baseline, after completion of the intervention, and at a 3-month follow-up. The study aims to examine changes in PTSD symptoms and related psychological outcomes over the course of treatment and follow-up.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Post Traumatic Stress Disorder Mental Disorders Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Community Stress Prevention Center

Kiryat Shmona, Israel

Location status: Recruiting

Location contact

Meital Mashash, PhD

CONTACT

[email protected]

972-50-2888052

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants must meet all of the following criteria:

  • Age 18 years or older
  • PTSD symptoms, defined as a PCL-5 score of 30 or above
  • Able to provide informed consent
  • Willing and able to participate in 12 weekly individual therapy sessions and complete study questionnaires at baseline, post-intervention, and 3-month follow-up Exclusion Criteria

Participants will be excluded if they meet any of the following criteria:

  • Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes.
  • Currently receiving psychotherapy of any type that began less than 3 months prior to enrolment.
  • Initiation of psychiatric medication less than 3 months prior to enrolment.

Treatment and study plan

SEE FAR CBT

Behavioral

SEE FAR CBT is a trauma-focused cognitive-behavioral treatment approach. Participants will receive 12 therapeutic sessions delivered approximately once weekly as a structured psychological intervention for PTSD.

Primary outcomes

  1. Change in PTSD symptoms

    Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention

    PTSD Checklist for DSM-5 (PCL-5). PTSD symptoms will be assessed using the PCL-5. Total scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity. Change in PCL-5 total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up.

  2. Change in anxiety symptoms

    Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention

    Generalized Anxiety Disorder-7 (GAD-7). Anxiety symptoms will be assessed using the GAD-7. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity. Change in GAD-7 total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up.

Secondary outcomes

  1. Change in depressive symptoms

    Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention

    Patient Health Questionnaire-9 (PHQ-9). Depressive symptoms will be assessed using the PHQ-9. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity. Change in PHQ-9 total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up.

  2. Change in perceived stress

    Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention

    Perceived Stress Scale (PSS). Perceived stress will be assessed using the PSS. Total scores range from 0 to 40, with higher scores indicating greater perceived stress. Change in PSS total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up.

  3. Change in resilience

    Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention

    Connor-Davidson Resilience Scale (CD-RISC-10). Resilience will be assessed using the CD-RISC. Total scores range from 0 to 40, with higher scores indicating greater resilience. Change in CD-RISC total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up.

  4. Change in somatic symptoms

    Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention

    Patient Health Questionnaire-15 (PHQ-15). Somatic symptoms will be assessed using the PHQ-15. Total scores range from 0 to 30, with higher scores indicating greater somatic symptom severity. Change in PHQ-15 total score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up.

  5. Change in trauma-related use of imagination and coping

    Time frame: Baseline, 12-16 weeks after baseline, and 3 months after completion of the intervention

    Fantastic Reality Ability Measurement (FRAME). Trauma-related use of imagination and coping will be assessed using the FRAME questionnaire. The FRAME is a 21-item measure of fantastic reality ability, defined as the capacity to use imagination in response to stress or trauma. Items are rated on a 1-7 Likert scale, and mean scores range from 1 to 7, with higher scores indicating greater fantastic reality ability. Change in FRAME score will be examined from baseline to post-intervention, from baseline to 3-month follow-up, and from post-intervention to 3-month follow-up.

Study contacts

Contact information is provided by the study sponsor or research team.

Meital Mashash, PhD

CONTACT

[email protected]

972-50-2888052

Sivan Raz, PhD

CONTACT

[email protected]

972-54-6634301

Sponsors and collaborators

Lead sponsor

Community Stress Prevention Center

Other

Registry information

Official study title

A Clinical Study Evaluating the Effects of a SEE FAR CBT Intervention on Psychological Outcomes in Adults With Posttraumatic Stress Disorder.

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Jul 22, 2026
Registry last updated
Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.